Clinical Trials Browser

Completed × OTHER × Prostatic Neoplasms × Clear all

NCT03570827 2026-05-26

Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy

Phase 2 Completed

53 enrolled 11 charts

Prostatic Neoplasms

NCT03934840 2026-05-26

CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone

Phase 2 Completed

61 enrolled 16 charts

Prostatic Neoplasms

NCT03421015 2026-05-22

CHRU-WCMC

Prostatic Neoplasms, Recurrence

NCT03503643 2026-05-22

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Prostatic Diseases, Prostatic Neoplasms

NCT04687969 2026-05-22

Multimodal Machine Learning Characterization of Solid Tumors

CNSGastrointestinalGenitourinary

Carcinoma, Renal Cell, Glioma, Carcinoma, Hepatocellular, Prostatic Neoplasms

NCT01823562 2026-05-20

Aborption and Metabolism of Lyophilized Black Raspberry Food Products in Men With Prostate Cancer Undergoing Surgery

Phase 1 Completed

60 enrolled 12 charts

Prostatic Neoplasms

NCT04037254 2026-05-20

Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring

Phase 1/2 Completed

22 enrolled 13 charts

Prostatic Neoplasms

NCT02397317 2026-05-19

SPARK

Phase NA Completed

Prostatic Neoplasms

NCT03606837 2026-05-19

PROSTATEP

Phase 2 Completed

Prostatic Neoplasms

NCT05146297 2026-05-19

DISRUPT

Phase NA Completed

BreastGastrointestinalGenitourinary

Breast Neoplasms, Liver Neoplasms, Prostatic Neoplasms

NCT00911118 2026-05-18

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Phase 1 Completed

Adenocarcinoma, Prostatic Neoplasms

NCT06298305 2026-05-18

QUANTIB

Prostatic Neoplasms

NCT04019964 2026-05-15

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Phase 2 Completed

8 enrolled 12 charts

Prostatic Neoplasms

NCT05730712 2026-05-15

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

7 enrolled 10 charts

Prostatic Neoplasms

NCT06807398 2026-05-15

RF-2018-123683

Adenocarcinoma, Prostatic Neoplasms

NCT07485257 2026-05-15

MP-PET-MRI

Prostatic Neoplasms

NCT07491406 2026-05-15

PRS-AS

Genetic Risk Score, Prostatic Neoplasms

NCT03604757 2026-05-14

UROPET

Phase 2 Completed

Prostatic Neoplasms

NCT03644303 2026-05-14

TRAP

Phase NA Completed

86 enrolled 27 charts

Neoplasm Metastasis, Prostatic Neoplasms

NCT01624220 2026-05-12

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Phase NA Completed

41 enrolled 8 charts

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Prostatic Neoplasms, Sarcoma, Spinal Cord Neoplasms, Thyroid Neoplasms

NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Phase 2 Completed

30 enrolled 13 charts

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

NCT07462403 2026-05-08

A Prolonged Nightly Fasting for Men on ADT for PCa

Phase NA Completed

Prostatic Neoplasms

NCT02206334 2026-05-07

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Phase 1 Completed

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Breast Neoplasms, Male

NCT03123978 2026-05-06

Enzalutamide and Niclosamide in Treating Patients With Recurrent or Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT04565457 2026-05-06

A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality

Phase NA Completed

43 enrolled 17 charts

GenitourinaryHead & Neck

Head and Neck Neoplasms, Prostatic Neoplasms

NCT04726319 2026-05-06

FHAMe

Phase NA Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Type 2, Melanoma, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT05375539 2026-05-06

AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients

Phase 1 Completed

12 enrolled 13 charts

Prostatic Neoplasms

NCT06575361 2026-05-06

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

Phase NA Completed

Disease, Prostatic Neoplasms

NCT07568444 2026-05-06

Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

Phase 2 Completed

Adenocarcinoma, Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms, Testicular Neoplasms

NCT06661044 2026-04-30

EVENTIDE

Adenocarcinoma, Prostatic Neoplasms

NCT04558398 2026-04-29

ICCE-Mito

Phase NA Completed

GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

NCT05133440 2026-04-28

A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

Phase 2 Completed

Prostatic Neoplasms

NCT04305925 2026-04-24

Focal Laser Ablation of Prostate Cancer

Phase EARLY_PHASE1 Completed

Prostatic Neoplasms

NCT02104362 2026-04-23

SiFEPI

Phase NA Completed

Prostatic Neoplasms

NCT04925648 2026-04-23

PICASSO

Phase 2 Completed

Prostatic Neoplasms

NCT07533344 2026-04-16

PSMA-MRI BX

Prostatic Neoplasms

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT01902680 2026-04-14

CURIEFOCALE

Phase 2 Completed

Prostatic Neoplasms

NCT02772588 2026-04-13

AASUR in High Risk Prostate Cancer

Phase 2 Completed

64 enrolled 7 charts

Prostatic Neoplasms

NCT04081779 2026-04-08

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Phase NA Completed

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Prostatic Neoplasms, Colorectal Neoplasms

NCT04533958 2026-04-06

HypProMet

Phase NA Completed

Anxiety Disorders, Neoplasms, Prostatic Neoplasms

NCT03660085 2026-04-03

PC-PEP

Phase NA Completed

140 enrolled 8 charts

Psychological Well-Being, Motor Activity, Prostatic Neoplasms

NCT05553327 2026-04-01

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

Phase NA Completed

Prostatic Neoplasms

NCT03496805 2026-03-31

Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

Phase 2 Completed

106 enrolled 10 charts

Prostatic Neoplasms

NCT03674814 2026-03-31

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT05231915 2026-03-31

HOXB13_Mart

Phase NA Completed

Prostatic Neoplasms

NCT04705038 2026-03-27

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Phase NA Completed

Prostatic Neoplasms

NCT06435546 2026-03-27

AdOTAC

Phase NA Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07074405 2026-03-27

AccAI

Phase NA Completed

Prostatic Neoplasms

NCT04461509 2026-03-25

High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy

Phase 2 Completed

62 enrolled 11 charts

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms